Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-22

Clinical Trial Update: Dose-finding Study of Moxidectin for Treatment of Scabies [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding trial of moxidectin for the treatment of scabies has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Moxidectin (moxidectin)

Snippet

Sponsor: Medicines Development for Global Health | Conditions: Scabies | Phase 2 | Status: COMPLETED | Results posted: 2023-09-22